CPhI logo
  • Products
  • Suppliers
  • Sourcing Requests
  • 中文站
  • Sign in Join free
Post Sourcing Request Post Sourcing Request Sourcing Request List Exhibition
  • Home
  • Products
  • Suppliers
  • Content Hub
  • Industry Insights
  • Events
  • Service & Membership
  • For Suppliers

    My Account

    My Online Store

    My EZSourcing

    View Sourcing Requests

    Customer Service

  • For Buyer

    Search Products & Suppliers

    Products Directory Suppliers Discovery Post EZSourcing

    Service

    Buyer Sourcing Event Contact Us

    Quick links

    My Favorites Recent Visit History
  • Industry Data
  • Features
  • Market News
  • Products Guide
  • Brand Story
You are here:   Industry Insights > COVID-19

News List

  • Synthesis technology of cepharanthine, a "specific drug" for coronavirus Industry Data PharmaSources/YuntianMay 25, 2022
    ​Recently, cepharanthine, first discovered in China as the new drug for treating COVID-19, has recently been granted the national invention patent authorization, which has drawn great attention from inside and outside the industry.
  • New Improvement in Universal Vaccines and Long-acting Neutralizing Antibodies Industry Data PharmaSources/YefenghongMay 25, 2022
    COVID-19 has spread rapidly since the winter of 2019, and even today, the whole world is still shrouded in its haze.
  • Is mRNA Vaccine the Source of Intricacies of "Mysterious Hepatitis"? Industry Data PharmaSources/YefenghongMay 23, 2022
    3 years into the COVID-19 pandemic, it has had a significant impact on human health and economic development. Based on WHO statistics, as of April 22, there are approximately 497 million confirmed patients and 6.179 million deaths in the world because of
  • The Oral Vaccine Market and Technology Industry Data PharmaSources/David OrchardMay 12, 2022
    A vaccine is a biologic that improves immunity to disease. Vaccination is considered the most effective means of controlling infectious disease-related morbidity and mortality.
  • Breakthrough in Research of Small Molecule Drugs against SARS-CoV-2 Industry Data PharmaSources/XiaonishaMarch 21, 2022
    Corona virus disease 2019 (COVID-19) caused by a novel single-stranded RNA coronavirus has swept the world. The International Committee on Taxonomy of Viruses (ICTV) named the virus SARS-CoV-2.
  • To Win the Fight against COVID-19 in the Future, How To Make a Breakthrough in the R&D of New Drug? Industry Data PharmaSources/Professor in medical fieldMarch 21, 2022
    Recently, with the continuous evolution and spread of Novel Coronavirus variant (including Delta-related variant viruses) all over the world, the mortality rate in some areas has a tendency to increase.
  • Weekly Pharmaceutical News Review | PharmaSources.com (Feb. 28th to March.4th) Industry Data PharmaSources.comMarch 16, 2022
    The most talked-about news of this week is the successful overseas marketing of Nanjing LEGN.US's CAR-T, which not only demonstrates the strength of China's innovative biologics but also eases the anxiety of Chinese innovative drug companies.
  • Africa Expands Vaccine Manufacturing Capacity Features Shem OirereMarch 08, 2022
    The outbreak of COVID-19 pandemic has revived the drive by governments in Africa to expand local pharmaceutical manufacturing so as to increase access to affordable quality medicines for the continent’s 1.3 billion people.
  • FDA Stops Two COVID-19 Rapid Diagnostics Tests Features Lin ZhangMarch 01, 2022
    The coronavirus (COVID-19) pandemic has been around for more than two years. While in many ways the world is returning to normal, the wave of Omicron and continued cases of COVID-19 still need to be addressed.
  • Increased COVID-19 testing triggers demand for kit reagents Features Shem OirereFebruary 22, 2022
    The emerging new mutations of COVID-19 is fueling the global drive for mass testing hence increasing demand for reagents for both testing kits and vaccine production especially in low- and middle-income countries.
Previous page 1 2 3 4 5 6 7 8 ... 436 437 Next page

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPhI China
P-MEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
  • Copyright 2006-2022 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182
  • Links:
    CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
  • Follow Us:

  • CPhI logo Pharma Sources Insight JUNE2022
  • PharmaSources@imsinoexpo.com
  • +86-13621645194
  • We Want Your Feedback